NVAX
Novavax Inc
NASDAQ: NVAX · HEALTHCARE · BIOTECHNOLOGY
$7.93
-0.56% today
Updated 2026-04-30
Market cap
$1.31B
P/E ratio
3.09
P/S ratio
1.17x
EPS (TTM)
$2.58
Dividend yield
—
52W range
$6 – $12
Volume
4.2M
WallStSmart proprietary scores
54
out of 100
Grade: C
Hold
Investment rating
4.7
Growth
C6.5
Quality
B7.0
Profitability
B+7.0
Valuation
B+5/9
Piotroski F-Score
Moderate
-2.8
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$14.00
+76.66%
12-Month target
$7.47
-5.74%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy5 Buy1 Hold1 Sell2 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 39.20% — above average
+ Revenue growth 66.60% QoQ
+ Debt/equity -1.60x — low leverage
Risks
- Altman Z -2.81 — distress zone
- Negative free cash flow $-41.55M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.60B | $556.38M | $682.16M | $1.12B | $1.12B |
| Net income | $-657.94M | $-545.06M | $-187.50M | $440.30M | $17.53M |
| EPS | — | — | — | — | $2.58 |
| Free cash flow | $-508.92M | $-772.77M | $-100.32M | $-250.19M | $-41.55M |
| Profit margin | -41.15% | -97.97% | -27.49% | 39.19% | 39.20% |
Peer comparison
Smart narrative
Novavax Inc trades at $7.93. representing a P/E of 3.09x trailing earnings. Our Smart Value Score of 54/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -2.81, it sits in the distress. TTM revenue stands at $1.12B. with profit margins at 39.20%.
Frequently asked questions
What is Novavax Inc's stock price?
Novavax Inc (NVAX) trades at $7.93.
Is Novavax Inc overvalued?
Smart Value Score 54/100 (Grade C, Hold).
What is the price target of Novavax Inc (NVAX)?
The analyst target price is $14.00, representing +76.7% upside from the current price of $7.93.
What is Novavax Inc's revenue?
TTM revenue is $1.12B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
-2.81 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.17x
ROE-898.00%
Beta2.65
50D MA$9.12
200D MA$8.19
Shares out0.16B
Float0.14B
Short ratio—
Avg volume4.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—